OIG: NDC directory is replete with flaws
OIG has found that the FDA's National Drug Code Directory, which lists prescription drugs by their NDC number, is neither complete nor accurate. More than 9,000 products are missing, and more than 34,000 are either listed in error or no longer on the market.
OIG: NDC directory is replete with flaws
OIG has found that the FDA's National Drug Code Directory, which lists prescription drugs by their NDC number, is neither complete nor accurate. More than 9,000 products are missing, and more than 34,000 are either listed in error or no longer on the market. OIG gave the agency seven suggestions on how to update its directory. The FDA concurred with OIG's recommendations, adding that it is converting to an electronic listing system for use by drug firms. To access the OIG report, go to http://oig.hhs.gov/oei/reports/oei-06-05-00060.pdf.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
